The Assistance Fund (TAF) Duchenne Muscular Dystrophy Financial Assistance Program

The Assistance Fund's Duchenne Muscular Dystrophy Financial Assistance Program offers grants to U.S. citizens or permanent residents diagnosed with DMD who are prescribed an FDA-approved treatment and meet financial eligibility criteria based on household income and size. The program covers various out-of-pocket medical expenses, including prescription drug costs, health insurance premiums, therapy administration, and disease management. For travel, it provides financial aid for travel to treatment centers or prescribing physicians, encompassing ground transportation, air travel, meals, and hotel stays.

Eligibility

Applicants must be U.S. citizens or permanent residents diagnosed with Duchenne Muscular Dystrophy and prescribed an FDA-approved treatment with existing prescription coverage. They must also meet undisclosed financial eligibility criteria based on household income and size.